These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 20047477

  • 21. Tafenoquine for Relapsing Babesiosis: A Case Series.
    Krause PJ, Rogers R, Shah MK, Kang H, Parsonnet J, Kodama R, Vannier E.
    Clin Infect Dis; 2024 Jul 19; 79(1):130-137. PubMed ID: 38814096
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens.
    Pudney M, Gray JS.
    J Parasitol; 1997 Apr 19; 83(2):307-10. PubMed ID: 9105316
    [Abstract] [Full Text] [Related]

  • 23. Babesiosis in the immediate postoperative period after splenectomy for trauma.
    Semel ME, Tavakkolizadeh A, Gates JD.
    Surg Infect (Larchmt); 2009 Dec 19; 10(6):553-6. PubMed ID: 19622029
    [Abstract] [Full Text] [Related]

  • 24. Babesiosis in humans: a treatment review.
    Weiss LM.
    Expert Opin Pharmacother; 2002 Aug 19; 3(8):1109-15. PubMed ID: 12150690
    [Abstract] [Full Text] [Related]

  • 25. [Babesiosis in an immunocompromised German patient].
    Häselbarth K, Kurz M, Hunfeld KP, Krieger G.
    Med Klin (Munich); 2008 Feb 15; 103(2):104-7. PubMed ID: 18270666
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The treatment of babesiosis.
    Ranque S.
    N Engl J Med; 2001 Mar 08; 344(10):773-4. PubMed ID: 11236790
    [No Abstract] [Full Text] [Related]

  • 28. Persistent parasitemia after acute babesiosis.
    Krause PJ, Spielman A, Telford SR, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH.
    N Engl J Med; 1998 Jul 16; 339(3):160-5. PubMed ID: 9664092
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. First case of human babesiosis in Germany - Clinical presentation and molecular characterisation of the pathogen.
    Häselbarth K, Tenter AM, Brade V, Krieger G, Hunfeld KP.
    Int J Med Microbiol; 2007 Jun 16; 297(3):197-204. PubMed ID: 17350888
    [Abstract] [Full Text] [Related]

  • 31. Successful prevention and treatment of babesiosis with atovaquone.
    Hughes WT, Oz HS.
    J Infect Dis; 1995 Oct 16; 172(4):1042-6. PubMed ID: 7561178
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitory effects of 19 antiprotozoal drugs and antibiotics on Babesia microti infection in BALB/c mice.
    Yao JM, Zhang HB, Liu CS, Tao Y, Yin M.
    J Infect Dev Ctries; 2015 Sep 27; 9(9):1004-10. PubMed ID: 26409742
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro.
    Matsuu A, Koshida Y, Kawahara M, Inoue K, Ikadai H, Hikasa Y, Okano S, Higuchi S.
    Vet Parasitol; 2004 Sep 20; 124(1-2):9-18. PubMed ID: 15350657
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.